Cantor Fitzgerald’s Merck MRK Stock Holding History

Cantor Fitzgerald’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,826	Closed	-$1.3M	–	299
2024 Q1	$1.3M	Buy	9,826 +4,205	+75%	+$518K	0.31%	46
2023 Q4	$613K	Sell	5,621 -365,153	-98%	-$37.9M	0.13%	85
2023 Q3	$38.2M	Sell	370,774 -174,545	-32%	-$18.8M	1.02%	18
2023 Q2	$62.9M	Sell	545,319 -14,549	-3%	-$1.65M	1.44%	8
2023 Q1	$59.6M	Sell	559,868 -836	-0.1%	-$90.3K	1.27%	7
2022 Q4	$62.2M	Sell	560,704 -59,295	-10%	-$6.06M	1.34%	5
2022 Q3	$53.4M	Buy	619,999 +66,758	+12%	+$5.96M	1.17%	10
2022 Q2	$67.9M	Buy	+553,241	New	+$49M	1.32%	4

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cantor Fitzgerald's MRK Position: Q2 2024 in Review

Cantor Fitzgerald sold out of Merck (MRK) in Q2 2024, closing a stake of 9,826 shares — an estimated $1.3M sold.

Cantor Fitzgerald first reported a position in MRK in Q2 2022 and held it in 8 quarters. The position peaked at $67.9M in Q2 2022. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Cantor Fitzgerald reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Cantor Fitzgerald sold 9,826 Merck shares in Q2 2024, an estimated $1.3M.
Cantor Fitzgerald first reported a position in Merck in Q2 2022 and held it in 8 quarters.
Cantor Fitzgerald's Merck position peaked at $67.9M in Q2 2022.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.